US Blue Biotechnology Market - Marine-Derived Therapeutics and Clinical Advancement
Market Overview The US blue biotechnology market is experiencing clinical translation emphasis where marine-derived compounds advance through clinical development, demonstrate therapeutic efficacy, and receive regulatory approval for diverse medical applications. The US blue biotechnology market is projected to exceed USD 8 billion through 2030, with clinical emphasis driven by therapeutic...
0 Commenti 0 condivisioni 15 Views 0 Anteprima